Quarterly report pursuant to Section 13 or 15(d)

3. Equity (Details Narrative)

v3.20.2
3. Equity (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 15, 2020
Sep. 30, 2019
Share-based compensation expense $ 930,443   $ 286,778
Options [Member]      
Share-based compensation expense $ 930,443   $ 286,778
Options granted 561,236    
Option exercise price $ 2.27    
Unrecognized compensation expense $ 2,621,446    
Aggregate intrinsic value options vested 469,316    
Aggregate intrinsic value options exercisable 469,316    
Warrants [Member]      
Aggregate intrinsic value of warrants vested and exercisable $ 2,605,900    
2017 Stock Plan [Member]      
Shares authorized under plan 2,000,000    
Shares remaining for issuance 0    
2020 Stock Plan [Member]      
Shares authorized under plan 3,000,000    
Shares remaining for issuance 2,799,264    
Employees, Scientific Advisory Board and Board of Directors [Member] | Options [Member]      
Options granted 561,236    
Option expiration period 10 years    
Fair value of options granted $ 1,115,508    
Employees, Scientific Advisory Board and Board of Directors [Member] | Options [Member] | Minimum [Member]      
Option exercise price $ 2.06    
Employees, Scientific Advisory Board and Board of Directors [Member] | Options [Member] | Maximum [Member]      
Option exercise price $ 2.47    
Purchase Agreement [Member] | Lincoln Park [Member]      
Common stock issued for commitment fee   201,991  
Value of stock issued   $ 395,902